Neisseria meningitidis group a capsular polysaccharide diphtheria toxoid conjugate antigen

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Brand Names
Menactra
Generic Name
Neisseria meningitidis group a capsular polysaccharide diphtheria toxoid conjugate antigen
DrugBank Accession Number
DB10798
Background

Neisseria meningitidis group a capsular polysaccharide diphtheria toxoid conjugate antigen is an active intramuscular immunization for the prophylaxis of invasive meningococcal disease caused by Neisseria meningitidis serogroup a. The vaccine contains N. meningitis serogroup a capsular polysaccharide antigens that are purified and individually conjugated to diphtheria toxoid protein that are extracted from Corynebacterium diphtheriae grown in another culture.

Type
Biotech
Groups
Approved, Investigational
Biologic Classification
Vaccines
Toxoid
Synonyms
  • Neisseria meningitidis serogroup A capsular polysaccharide diphtheria toxoid protein conjugate vaccine

Pharmacology

Indication

Not Available

Pharmacology
Accelerate your drug discovery research with the industry’s only fully connected ADMET dataset, ideal for:
Machine Learning
Data Science
Drug Discovery
Accelerate your drug discovery research with our fully connected ADMET dataset
Learn more
Associated Conditions
Contraindications & Blackbox Warnings
Contraindications
Contraindications & Blackbox Warnings
With our commercial data, access important information on dangerous risks, contraindications, and adverse effects.
Learn more
Our Blackbox Warnings cover Risks, Contraindications, and Adverse Effects
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Medicalerrors
Reduce medical errors
and improve treatment outcomes with our comprehensive & structured data on drug adverse effects.
Learn more
Reduce medical errors & improve treatment outcomes with our adverse effects data
Learn more
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Products

Products
Comprehensive & structured drug product info
From application numbers to product codes, connect different identifiers through our commercial datasets.
Learn more
Easily connect various identifiers back to our datasets
Learn more
Mixture Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
MenactraNeisseria meningitidis group a capsular polysaccharide diphtheria toxoid conjugate antigen (4 ug/0.5mL) + Neisseria meningitidis group c capsular polysaccharide diphtheria toxoid conjugate antigen (4 ug/0.5mL) + Neisseria meningitidis group w-135 capsular polysaccharide diphtheria toxoid conjugate antigen (4 ug/0.5mL) + Neisseria meningitidis group y capsular polysaccharide diphtheria toxoid conjugate antigen (4 ug/0.5mL)Injection, solutionIntramuscularSanofi Pasteur Inc.2005-01-14Not applicableUS flag
MenactraNeisseria meningitidis group a capsular polysaccharide diphtheria toxoid conjugate antigen (4 mcg/mL) + Neisseria meningitidis group c capsular polysaccharide diphtheria toxoid conjugate antigen (4 mcg/mL) + Neisseria meningitidis group w-135 capsular polysaccharide diphtheria toxoid conjugate antigen (4 mcg/mL) + Neisseria meningitidis group y capsular polysaccharide diphtheria toxoid conjugate antigen (4 mcg/mL)SolutionIntramuscularSanofi Pasteur Limited2006-10-20Not applicableCanada flag
MenactraNeisseria meningitidis group a capsular polysaccharide diphtheria toxoid conjugate antigen (4 ug/0.5mL) + Neisseria meningitidis group c capsular polysaccharide diphtheria toxoid conjugate antigen (4 ug/0.5mL) + Neisseria meningitidis group w-135 capsular polysaccharide diphtheria toxoid conjugate antigen (4 ug/0.5mL) + Neisseria meningitidis group y capsular polysaccharide diphtheria toxoid conjugate antigen (4 ug/0.5mL)Injection, solutionIntramuscularRemedy Repack2015-01-032016-03-29US flag
MENACTRANeisseria meningitidis group a capsular polysaccharide diphtheria toxoid conjugate antigen (4 mcg/0.5ml) + Neisseria meningitidis group c capsular polysaccharide diphtheria toxoid conjugate antigen (4 mcg/0.5ml) + Neisseria meningitidis group w-135 capsular polysaccharide diphtheria toxoid conjugate antigen (4 mcg/0.5ml) + Neisseria meningitidis group y capsular polysaccharide diphtheria toxoid conjugate antigen (4 mcg/0.5ml)SolutionIntramuscularบริษัท ซาโนฟี่ ปาสเตอร์ จำกัด2015-02-17Not applicableThailand flag

Categories

Drug Categories
Classification
Not classified
Affected organisms
Not Available

Chemical Identifiers

UNII
RE9A0H8OAB
CAS number
Not Available

References

General References
Not Available
PubChem Substance
347910904
RxNav
797629

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
4Active Not RecruitingPreventionMeningococcal Disease, Invasive1
4CompletedPreventionAcellular Pertussis / Diphtheria / Tetanus1
4CompletedPreventionDiphtheria / Haemophilus Influenzae Serotype b (Hib) / Meningitis / Meningococcal Infections / Pertussis / Tetanus1
4CompletedPreventionFlu caused by Influenza1
4CompletedPreventionMeningitis1
4CompletedPreventionMeningitis / Meningococcal Infections / Meningococcal Meningitis1
4Not Yet RecruitingPreventionPreventive Immunization; Meningitis1
3Active Not RecruitingPreventionMeningococcal Meningitis1
3CompletedPreventionDiphtheria / Meningitis / Neoplasms, Glandular and Epithelial / Tetanus / Whooping Cough1
3CompletedPreventionHuman Papillomavirus Infections1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
Injection, solutionIntramuscular
SolutionIntramuscular
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available

Drug created on December 01, 2015 20:04 / Updated on June 12, 2020 16:53